Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04400435 · ClinicalTrials.gov registry record
Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence
A clinical trial, sponsored by Eko Devices.
- Completed
- Registry status
- 1,258
- Enrollment target
NCT04400435: Completed study, sponsored by Eko Devices.
NCT04400435 is a clinical trial that has completed, run by Eko Devices. The registered enrollment target is 1,258 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04400435 has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 1,258 participants
- Enrollment target
Study Summary
The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
Primary Outcome
Evaluate performance of single-lead ECG based algorithm to identify individuals with reduced ejection fraction.
Interventions
- DEVICE Use of Eko DUO electronic stethoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,258 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2022-04-29 |
What the finished NCT04400435 record still lists
NCT04400435 is an observational study that tracks outcomes without assigning an intervention. Its 1,258 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko DUO electronic stethoscope is the first listed.
NCT04400435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04400435 about?
NCT04400435 is a clinical study titled "Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence". The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
What is the current status of trial NCT04400435?
This trial is currently completed. The enrollment target is 1,258 participants. The study started on 2020-07-15. Estimated completion is 2022-04-29.
What interventions are being tested in trial NCT04400435?
The interventions under investigation include: Use of Eko DUO electronic stethoscope (DEVICE).
Who is sponsoring clinical trial NCT04400435?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI